{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:19:53Z","timestamp":1794057593038,"version":"4.8.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":1913,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","fertstert.org","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.fertnstert.2016.12.017","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T10:53:19Z","timestamp":1484218399000},"page":"788-795.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life"],"prefix":"10.1016","volume":"107","author":[{"given":"Pekka","family":"Pinola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katri","family":"Puukka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terhi T.","family":"Piltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Puurunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Vanky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger","family":"Sundstr\u00f6m-Poromaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Stener-Victorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Lind\u00e9n Hirschberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille","family":"Ravn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Skovsager Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte","family":"Glintborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Roar","family":"Mellembakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimo","family":"Ruokonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha S.","family":"Tapanainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure C.","family":"Morin-Papunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2016.12.017_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib3","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1210\/jc.2011-0039","article-title":"Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS","volume":"96","author":"Puurunen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib4","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2014.08.001","article-title":"Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?","volume":"102","author":"Daan","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3109\/09513590.2012.671389","article-title":"Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population","volume":"28","author":"Johnstone","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib6","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/humrep\/15.6.1266","article-title":"Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome","volume":"15","author":"Morin-Papunen","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.02764.x","article-title":"Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome","volume":"66","author":"Barber","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib8","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1210\/jc.2006-1327","article-title":"Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features","volume":"91","author":"Welt","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/hmbci-2013-0014","article-title":"The impact of hyperandrogenism in female obesity and cardiometabolic diseases associated with polycystic ovary syndrome","volume":"15","author":"Barber","year":"2013","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib10","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"O\u2019Reilly","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.fertnstert.2013.11.027","article-title":"Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome","volume":"101","author":"Sung","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2265.2009.03614.x","article-title":"Association of insulin resistance with anti-m\u00fcllerian hormone levels in women without polycystic ovary syndrome (PCOS)","volume":"72","author":"Park","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib13","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MED.0b013e32832afd4d","article-title":"Androgens and polycystic ovary syndrome","volume":"16","author":"Nisenblat","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib15","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1210\/jc.2010-2959","article-title":"Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib16","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1210\/jc.2013-4170","article-title":"Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition","volume":"99","author":"Polotsky","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1055\/s-0030-1262902","article-title":"Metabolic implications of menopause","volume":"28","author":"Polotsky","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/gme.0b013e31802b6cb1","article-title":"Endogenous androgen levels and cardiovascular risk profile in women across the adult life span","volume":"14","author":"Bell","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/ije\/dyv093","article-title":"Sex hormone-binding globulin associations with circulating lipids and metabolites and the risk for type 2 diabetes: observational and causal effect estimates","volume":"44","author":"Wang","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.0001-6349.2004.00373.x","article-title":"Clinical, biochemical and ultrasonographic characteristics of Scandinavian women with PCOS","volume":"83","author":"Vanky","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib21","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1210\/jc.2008-2583","article-title":"Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome","volume":"94","author":"Puurunen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib22","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1210\/jc.2009-1908","article-title":"Are there any sensitive and specific sex steroid markers for polycystic ovary syndrome?","volume":"95","author":"Stener-Victorin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib23","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/humrep\/den482","article-title":"Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve","volume":"24","author":"Hudecova","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib24","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1210\/jc.2003-031851","article-title":"Ovarian age-related responsiveness to human chorionic gonadotropin in women with polycystic ovary syndrome","volume":"89","author":"Piltonen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib25","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1093\/humrep\/des225","article-title":"Oral, transdermal and vaginal combined contraceptives induce an increase in markers of chronic inflammation and impair insulin sensitivity in young healthy normal-weight women: a randomized study","volume":"27","author":"Piltonen","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib26","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1055\/s-0032-1304608","article-title":"Age associated differences in prevalence of individual Rotterdam criteria and metabolic risk factors during reproductive age in 446 caucasian women with polycystic ovary syndrome","volume":"44","author":"Glintborg","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib27","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.fertnstert.2011.09.006","article-title":"Randomized comparison of the influence of dietary management and\/or physical exercise on ovarian function and metabolic parameters in overweight women with polycystic ovary syndrome","volume":"96","author":"Nybacka","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib28","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1210\/jc.2015-2123","article-title":"Androgen profile through life in women with polycystic ovary syndrome: a Nordic multicenter collaboration study","volume":"100","author":"Pinola","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/00365510410006694","article-title":"Nordic Reference Interval Project Bio-bank and Database (NOBIDA): a source for future estimation and retrospective evaluation of reference intervals","volume":"64","author":"Rustad","year":"2004","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib31","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.fertnstert.2014.01.023","article-title":"Cluster analysis of cardiovascular and metabolic risk factors in women of reproductive age","volume":"101","author":"Tzeng","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/humupd\/dmp008","article-title":"Metabolic features of the reproductive phenotypes of polycystic ovary syndrome","volume":"15","author":"Moran","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2298\/VSP0206593M","article-title":"Age and body mass related changes of cardiovascular risk factors in women with polycystic ovary syndrome","volume":"59","author":"Macut","year":"2002","journal-title":"Vojnosanit Pregl"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2265.1999.00701.x","article-title":"The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment","volume":"50","author":"Pasquali","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib35","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jama.1996.03540110036029","article-title":"A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction","volume":"276","author":"Stampfer","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.hjr.0000174791.47059.80","article-title":"Predictive accuracy of the SCORE risk function for cardiovascular disease in clinical practice: a prospective evaluation of 44,649 Austrian men and women","volume":"12","author":"Ulmer","year":"2005","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib37","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1210\/jc.2014-3886","article-title":"The potential implications of a PCOS diagnosis on a woman\u2019s long-term health using data linkage","volume":"100","author":"Hart","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib38","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2265.2010.03873.x","article-title":"Ethnic differences in Rotterdam criteria and metabolic risk factors in a multiethnic group of women with PCOS studied in Denmark","volume":"73","author":"Glintborg","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib39","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.2337\/diacare.27.9.2135","article-title":"Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort","volume":"27","author":"Ilanne-Parikka","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib40","doi-asserted-by":"crossref","first-page":"e0127111","DOI":"10.1371\/journal.pone.0127111","article-title":"Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study","volume":"10","author":"Nystrom","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2016.12.017_bib41","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1471-2458-7-220","article-title":"Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study","volume":"7","author":"Hildrum","year":"2007","journal-title":"BMC Public Health"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216630893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028216630893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T15:32:41Z","timestamp":1718983961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028216630893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0015028216630893"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.12.017","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2016.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92016 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}